Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1CNS 1

Conditions

Brain Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Polycythemia Vera 4Glioblastoma 4Meningioma 3Leukemia, Myeloid, Acute 3Pharyngeal Neoplasms 2Paranasal Sinus Neoplasms 2Neoplasms 2Laryngeal Neoplasms 2Head and Neck Neoplasms 2Gliosarcoma 2Thrombocytosis 1Thrombocythemia, Essential 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Papillomavirus Infections 1Oropharyngeal Neoplasms 1Nose Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Glioma 1Epstein-Barr Virus Infections 1Carcinoma, Squamous Cell 1Carcinoma 1Astrocytoma 1Adenocarcinoma 1

Interventions

Gemcitabine 57Paclitaxel 50Cyclophosphamide 45pembrolizumab 44Carboplatin 41Bevacizumab 38Cisplatin 33Docetaxel 31Fluorouracil 30Nivolumab 29Capecitabine 29Pemetrexed 24Irinotecan 24Oxaliplatin 23Dexamethasone 23Ipilimumab 22Leucovorin 21Radiotherapy 20Sorafenib 19Doxorubicin 19Everolimus 18Cetuximab 18fludarabine 17Albumin-Bound Paclitaxel 17trametinib 15Sunitinib 15Rituximab 15Erlotinib Hydrochloride 15130-nm albumin-bound paclitaxel 15Prednisone 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Neoplasms × Hydroxyurea × Clear all
NCT00468169 2019-10-09

EPIC

University of Chicago

Phase 2 Completed
110 enrolled 14 charts
Head & Neck

Carcinoma, Head and Neck Neoplasms, Neoplasms

NCT00706810 2017-04-13

Combination of Hydroxyurea and Verapamil for Refractory Meningiomas

University of Utah

Phase 2 Completed
8 enrolled 5 charts
CNS

Brain Neoplasms, Meningioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡